EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RBE and OER within the spread-out Bragg peak for proton beam therapy: in vitro study at the Proton Medical Research Center at the University of Tsukuba



RBE and OER within the spread-out Bragg peak for proton beam therapy: in vitro study at the Proton Medical Research Center at the University of Tsukuba



Journal of Radiation Research 55(5): 1028-1032



There are few reports on the biological homogeneity within the spread-out Bragg peak (SOBP) of proton beams. Therefore, to evaluate the relative biological effectiveness (RBE) and the oxygen enhancement ratio (OER), human salivary gland tumor (HSG) cells were irradiated at the plateau position (position A) and three different positions within a 6-cm-wide SOBP (position B, 26 mm proximal to the middle; position C, middle; position D, 26 mm distal to the middle) using 155-MeV/n proton beams under both normoxic and hypoxic conditions at the Proton Medical Research Center, University of Tsukuba, Japan. The RBE to the plateau region (RBE(plateau)) and the OER value were calculated from the doses corresponding to 10% survival data. Under the normoxic condition, the RBE(plateau) was 1.00, 0.99 and 1.09 for positions B, C and D, respectively. Under the hypoxic condition, the RBE(plateau) was 1.10, 1.06 and 1.12 for positions B, C and D, respectively. The OER was 2.84, 2.60, 2.63 and 2.76 for positions A, B, C and D, respectively. There were no significant differences in either the RBE(plateau) or the OER between these three positions within the SOBP. In conclusion, biological homogeneity need not necessarily be taken into account for treatment planning for proton beam therapy at the University of Tsukuba.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333617

Download citation: RISBibTeXText

PMID: 24876271

DOI: 10.1093/jrr/rru043



Related references

Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas M.D. Anderson Cancer Center, Proton Therapy Center, Houston. Medical Physics 37(1): 154-163, 2010

Relative biological effectiveness in a proton spread-out Bragg peak formed by pencil beam scanning mode. Australasian Physical & Engineering Sciences in Medicine 40(2): 359-368, 2017

Effective generation of the spread-out-Bragg peak from the laser accelerated proton beams using a carbon-proton mixed target. Australasian Physical & Engineering Sciences in Medicine 37(4): 635-644, 2015

Stereotactic bragg peak proton beam therapy. Lunsford, L D (Ed ) Modern Stereotactic Neurosurgery Xv+519p Kluwer Academic Publishers: Dordrecht, Netherlands; Boston, Massachusetts, Usa Illus 463-470, 1988

Investigating the Implications of a Variable RBE on Proton Dose Fractionation Across a Clinical Pencil Beam Scanned Spread-Out Bragg Peak. International Journal of Radiation Oncology, Biology, Physics 95(1): 70-77, 2016

Initial experience of proton beam therapy at the new facility of the University of Tsukuba. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica 64(4): 225-230, 2004

Proton beam therapy for children with sarcomas: The University of Tsukuba experience. 2007

Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience. Cancer 115(23): 5499-5506, 2010

The Bragg peak of a proton beam in intracranial therapy of tumors. Transactions of the American Neurological Association 87: 216-218, 1962

The bragg peak of a proton beam in therapy of choroidal melanomas. Investigative Ophthalmology & Visual Science: 100, 1977

Bragg peak proton beam therapy for arteriovenous malformation of the brain. Clinical Neurosurgery 31: 248-290, 1983

Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. New England Journal of Medicine 309(5): 269-274, 1983

Prediction of output factor, range, and spread-out bragg peak for proton therapy. Medical Dosimetry 36(2): 145-152, 2011

Management of cushings disease and nelsons syndrome with bragg peak proton beam therapy. Clinical Research 25(3): 464A, 1977

Evaluation of the effect of soft tissue composition on the characteristics of spread-out Bragg peak in proton therapy. Journal of Cancer Research and Therapeutics 13(6): 974-980, 2017